Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Veracyte, Inc. Banner

Veracyte, Inc.

VCYT Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-29.373m-33.704m-31.358m-31.003m-22.999m-12.599m-34.909m-75.563m-36.560m-74.404m
Depreciation & Amortization
1.175M2.254M3.511M3.841M3.920M4.117M7.944M19.593M25.928M27.188M
Change in Working Capital
-945.000k550.000K-6.409m-5.443m-651.000k-4.846m-481.000k4.219M-16.381m-4.163m
Operating Cash Flow
-27.632m-26.965m-27.982m-23.915m-13.521m-3.232m-9.711m-31.621m7.535M44.222M
Capital Expenditure
-2.024m-6.165m-4.210m-1.755m-1.874m-2.756m-2.837m-5.376m-8.549m-9.961m
Free Cash Flow
-29.656m-33.130m-32.192m-25.670m-15.395m-5.988m-12.548m-36.997m-1.014m34.261M
Debt Repayment
-110.000k0.00019.164M-2.315m-292.000k-25.208m-100.000k0.000-1.281m0.000
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
10.078M37.258M31.949M200.000K55.038M137.848M193.831M593.821M7.942M9.578M
Common Stock Repurchased
-129.000k0.0000.0000.0000.0000.0000.0000.000-3.167m-6.741m
Net Change in Cash
-36.206m4.070M20.135M-25.328m44.104M81.322M190.047M-176.021m-18.950m62.334M